L-Theanine and Caffeine for Focus: What the Evidence Shows

L-theanine plus caffeine can modestly improve selective attention. The most interesting recent finding comes from sleep-deprived young adults: a single 200 mg L-theanine plus 160 mg caffeine dose improved attention-related brain signals measured in milliseconds, not merely participants' impressions of feeling alert.

That does not make the combination a general cognitive enhancer, a substitute for sleep, or a proven sports supplement. Across randomized trials, the clearest behavioral effects involve attention and reaction time. Memory, working memory, visual processing, and motor function have not shown the same benefit.

The sleep-deprivation study measured attention in the brain

In a double-blind, placebo-controlled, counterbalanced crossover trial, Nawarathna et al. (2025) gave 40 acutely sleep-deprived adults aged 22 to 30 either placebo or 200 mg L-theanine plus 160 mg caffeine. The study included 21 men and was powered to detect a moderate effect size of Cohen's d = 0.5 with 80% power.

The researchers assessed selective attention with behavioral tests and P3b event-related potentials, or ERPs. P3b amplitude reflects the neural resources allocated to attention. P3b latency reflects how quickly the brain updates its interpretation of a relevant stimulus. These are useful endpoints because they measure task-related neural processing rather than asking whether someone feels focused after a bad night.

The trial reported improved neurobehavioral and neurophysiological measures of selective attention after the combined dose in the sleep-deprived condition. Its result fits earlier ERP evidence cited by the authors: L-theanine, caffeine, and their combination produced larger P3b amplitudes than placebo in rested participants, while 400 mg L-theanine alone reduced P3b latency.

The result deserves interest, but not inflated certainty. This is one trial in young adults under acute, controlled sleep deprivation, and the full quantitative ERP results are not yet broadly available for independent scrutiny. It supports a plausible hypothesis that the high-dose combination can partly restore attention-related processing after short-term sleep loss. It does not establish that it restores normal cognition, offsets chronic sleep restriction, or applies to older adults, people with sleep disorders, or people with cognitive impairment.

A related double-blind crossover trial, Karunaratne et al. (2025), found that L-theanine alone improved reaction time and accuracy on a traffic-related selective-attention task in sleep-deprived young adults. That study does not prove that the combination works through theanine, but it strengthens the case that sleep deprivation is a condition in which theanine's attentional effects may be easier to detect.

The pooled behavioral effect is real, but narrow

The best broad estimate comes from a 2025 systematic review and meta-analysis by Payne et al. The authors pooled 50 randomized controlled trials of tea, L-theanine, and L-theanine plus caffeine in healthy participants. Their searches ran through August 2023, so the analysis does not include the 2025 sleep-deprivation studies.

For L-theanine plus caffeine compared with placebo, the pooled standardized mean difference for choice reaction time was −0.48, where a negative value means faster responses. Attention-switching accuracy improved by an SMD of +0.33. Both results were statistically significant after the authors used random-effects models with a conservative Knapp-Hartung adjustment.

Those are small-to-moderate average effects, not a cognitive transformation. They also do not show that every user will notice a meaningful improvement in daily work. Standardized effects compare groups across different tests; they do not translate cleanly into a universal number of milliseconds saved or emails answered before lunch.

The review's interpretation matters as much as its headline results. Caffeine appears to drive most of the combined behavioral effect through adenosine-receptor antagonism and the resulting increase in alertness and vigilance. L-theanine seems to add a more modest benefit, particularly for accuracy in some analyses above caffeine alone. If caffeine makes you jittery or disrupts your sleep, adding theanine does not repeal caffeine pharmacology with a polite green-tea flourish.

What human mechanism studies can actually say

Human evidence supports a restrained mechanism story. EEG findings cited in Nawarathna et al. indicate that 250 mg L-theanine produced a phasic increase in alpha power in visual-processing regions during task anticipation while suppressing background alpha activity. Researchers interpreted that pattern as improved target-versus-distractor discrimination.

Human fMRI findings cited in the same paper found lower responses to distractors in visual-attention regions and reduced activity in the right precuneus, a default-mode-network region associated with mind-wandering. Together, these observations support the possibility that L-theanine helps attention partly by reducing off-task processing.

They do not prove that L-theanine raises GABA, serotonin, or dopamine in the human brain. Claims about those neurochemical effects in this context rest on animal work; this evidence base contains no human PET receptor-occupancy studies or cerebrospinal-fluid measurements to confirm them.

Attention is not the same thing as memory

The limits show up clearly in Baba et al. (2021), a randomized placebo-controlled study in young adults aged 25 to 34. Participants consumed 2 g of matcha daily for two weeks before completing a mild psychological-stress paradigm. The matcha group maintained attentional function after stress, including lower Stroop reaction time than placebo.

But the study found no significant benefit for memory, working memory, visual information processing, motor function, or subjective fatigue. Matcha also contains catechins, caffeine, and other polyphenols, so its attentional result cannot isolate L-theanine plus caffeine as the cause.

Still, the null results are informative. The current evidence supports selective attention and response speed more than it supports broad claims about "brain power." A supplement that helps you filter a distractor may not help you remember a name, hold several numbers in mind, or improve fine motor control.

Athletic performance claims are preliminary

Two sport trials make the combination look more versatile than the evidence currently warrants. In a double-blind, placebo-controlled crossover study, Yilmaz et al. (2023) tested 22 elite curling athletes with 6 mg/kg L-theanine plus 6 mg/kg caffeine—about 420 mg of each compound for a 70 kg athlete. The study reported better shooting accuracy and cognitive-performance measures, including a partial eta-squared of 0.842 for the combined condition.

That effect estimate is far larger than the conventional threshold for a large partial eta-squared effect, 0.14. In a small crossover trial, such a result can reflect carryover or order effects, insufficient washout verification, or selection among multiple outcomes. The study did not pre-register a primary outcome, so it cannot provide confirmatory evidence for better athletic visuomotor performance.

Razazan et al. (2025) studied 12 elite wrestlers with a mean age of 17, using 3 mg/kg each of caffeine and L-theanine in a double-blind, placebo-controlled crossover design. The authors reported improvements in cognitive and wrestling-specific physical measures. With 12 participants, however, the trial had adequate power only for effects around d > 1.0. Small-to-moderate effects like those found in the meta-analysis are difficult to estimate reliably in a sample that small. Neither athletic study reported a pre-registered primary outcome or an a priori power calculation for its reported effects.

What dose makes sense?

Most trials in the meta-analysis used roughly 100 mg L-theanine with 50 to 100 mg caffeine. The sleep-deprivation ERP trial used 200 mg plus 160 mg. These protocols differ in dose, ratio, timing, tests, and populations, and no study in this evidence base directly compares them head to head.

• For ordinary attentional tasks, the lower-dose range has the broadest trial base.
• For acute sleep-deprivation conditions, 200 mg L-theanine plus 160 mg caffeine has the most direct neurophysiological evidence, but only from one trial.
• Escalating dose is an inference, not a demonstrated dose-response rule.

The evidence supports a modest, domain-specific tool for attention—not a way to turn insufficient sleep into adequate sleep.

If your goal is faster reactions and steadier selective attention, L-theanine plus caffeine has credible human evidence. Expect caffeine to do most of the heavy lifting, with theanine possibly improving accuracy and distractor control for some people. Expect neither compound combination to reliably improve memory or athletic performance. Sleep remains the intervention with the better résumé.